Pemivibart safe, effective for prevention of COVID-19 in immunocompromised cancer patients
The study assessed the safety and outcomes of pemivibart in the oncology subset from the open-label, single-arm, immunocompromised Cohort A of the phase
2026 ASCO
News
Leukemia
News
FDA approves pivekimab sunirine-pvzy for BPDCN
The drug had earlier received the FDA’s breakthrough designation and orphan drug designation, making the application eligible for priority review. Efficacy was evaluated
Lymphoma
Indolent B-Cell Lymphomas
No OS benefit to adding bendamustine to rituximab for marginal zone lymphoma
As a first-line treatment for patients with marginal zone lymphoma, the combination of bendamustine with rituximab (BR) conferred no advantage in overall survival
Soho Print
SOHO Insider 2026 print issue May/June
This issue of SOHO Insider features an article on US patient representation in global trials, an interview with Dr. Naval Daver, and photos
Lymphoma
Mantle Cell Lymphoma
FDA grants accelerated approval to sonrotoclax for relapsed or refractory mantle cell lymphoma
The US Food and Drug Administration has granted accelerated approval to sonrotoclax, a BCL-2 inhibitor, for adults with relapsed or refractory mantle cell
SOHO 2026
Trending now
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Aggressive B-Cell Lymphomas
Indolent B-Cell Lymphomas
Mantle Cell Lymphoma
T-Cell Lymphoma
News
Society Updates
Submit an abstract for SOHO 2026 by May 15
SOHO invites delegates and attendees to submit an abstract for a poster or oral presentation during the Fourteenth Annual Meeting of the Society
AACR 2026
Leukemia
Lymphoma
Myelodysplastic Syndromes
News
Is there a link between wildfire smoke and increased cancer risk?
In this interview from the AACR Annual Meeting 2026, Shuguang Leng, MBBS, PhD, an associate professor at the University of New Mexico Comprehensive
Trending now
Leukemia
Acute Myeloid Leukemia
News
Pathways & Perspectives with Naval Daver, MD
Meet Naval Daver, MD, a professor and director of the Leukemia Molecular Laboratory in the Department of Leukemia at the University of Texas
Trending now
Lymphoma
Aggressive B-Cell Lymphomas
SOHO Insider Podcast
Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer
In this SOHO Insider podcast, host Megan Melody, MD, from Tampa General Hospital, spoke with Nirav Shah, MD, professor at the Medical College
SOHO 2025
Ambassador Program
Lymphoma
Aggressive B-Cell Lymphomas
Multiple Myeloma
News
Dr. Raheel Iftikhar weighs in on AI in blood cancers
Dr. Iftikhar is the SOHO Ambassador to Pakistan and a consultant clinical hematologist and hematopoietic stem cell transplantation physician at Armed Forces Bone